Compare Lustrum:Mitsubishi Tanabe Pharma Corporation:4508

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Mitsubishi Tanabe Pharma Corporation Go to web site 4508 Medicals TSE March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Mitsubishi Tanabe Pharma Corporation Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Mitsubishi Tanabe Pharma Corporation Balance Sheet 2019年3月期 Mitsubishi Tanabe Pharma Corporation Balance Sheet 2018年3月期 Mitsubishi Tanabe Pharma Corporation Balance Sheet 2017年3月期 Mitsubishi Tanabe Pharma Corporation Balance Sheet 2016年3月期 Mitsubishi Tanabe Pharma Corporation Balance Sheet 2015年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016 March 31, 2015
Cash and Cash Equivalents
(Percent)
111,850down
(10.6%)down
127,030up
(12.1%)up
113,215down
(11.5%)down
239,174up
(25.0%)up
169,008
(18.2%)
Other Current AssetsHelp
(Percent)
476,583up
(45.1%)up
458,495down
(43.7%)down
570,544up
(58.0%)up
411,005down
(42.9%)down
434,641
(46.8%)
Tangible Fixed AssetsHelp
(Percent)

-

-

-

-

-
Intangible Fixed AssetHelp
(Percent)
298,558up
(28.3%)up
292,076up
(27.9%)up
141,537up
(14.4%)up
136,435up
(14.2%)up
116,919
(12.6%)
Investments and OthersHelp
(Percent)
95,700up
(9.1%)up
90,007up
(8.6%)up
72,923down
(7.4%)down
87,122down
(9.1%)down
116,236
(12.5%)
Total AssetsHelp
(Percent)
1,056,286
(100%)
1,048,444
(100%)
984,537
(100%)
958,445
(100%)
929,301
(100%)
Total Current LiabilitiesHelp
(Percent)
145,804down
(13.8%)down
153,197up
(14.6%)up
112,526down
(11.4%)down
131,416up
(13.7%)down
127,973
(13.8%)
Total Long-term LiabilitiesHelp
(Percent)
150down
(0.0%)down
420down
(0.0%)down
581down
(0.1%)down
713down
(0.1%)down
894
(0.1%)
Shareholder's EquityHelp
(Percent)
910,332up
(86.2%)up
894,827up
(85.3%)down
871,430up
(88.5%)up
826,316up
(86.2%)up
800,434
(86.1%)
Total LiabilitiesHelp
(Percent)
1,056,286
(100%)
1,048,444
(100%)
984,537
(100%)
958,445
(100%)
929,301
(100%)

Mitsubishi Tanabe Pharma Corporation Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Mitsubishi Tanabe Pharma Corporation Profit and Loss Account 2019年3月期 Mitsubishi Tanabe Pharma Corporation Profit and Loss Account 2018年3月期 Mitsubishi Tanabe Pharma Corporation Profit and Loss Account 2017年3月期 Mitsubishi Tanabe Pharma Corporation Profit and Loss Account 2016年3月期 Mitsubishi Tanabe Pharma Corporation Profit and Loss Account 2015年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016 March 31, 2015
Amount of Sales
(Percent)
424,767
(100%)
433,855
(100%)
423,977
(100%)
425,764
(100%)
415,124
(100%)
Total Sales
(Percent)
424,767
(100%)
433,855
(100%)
423,977
(100%)
425,764
(100%)
415,124
(100%)
Cost of SalesHelp
(Percent)
180,646up
(42.5%)up
169,750up
(39.1%)up
164,397up
(38.8%)up
155,802down
(36.6%)down
169,584
(40.9%)
Other Costs and RevenueHelp 206,749up
(48.7%)up
206,142up
(47.5%)up
188,317down
(44.4%)down
210,656up
(49.5%)down
206,038
(49.6%)
Total CostsHelp 387,395 375,892 352,714 366,458 375,622
Net RevenueHelp 244,121down
(57.5%)down
264,105up
(60.9%)down
259,580down
(61.2%)down
269,962up
(63.4%)up
245,540
(59.1%)
Earnings Before TaxHelp 50,439down
(11.9%)down
78,764down
(18.2%)down
96,059up
(22.7%)up
83,255up
(19.6%)up
67,654
(16.3%)
Net IncomeHelp 37,372down
(8.8%)down
57,963down
(13.4%)down
71,263up
(16.8%)up
59,306up
(13.9%)up
39,502
(9.5%)
当期純利益 37,372 57,963 71,263 59,306 39,502

Mitsubishi Tanabe Pharma Corporation Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Mitsubishi Tanabe Pharma Corporation Cash Flow Statement 2019年3月期 Mitsubishi Tanabe Pharma Corporation Cash Flow Statement 2018年3月期 Mitsubishi Tanabe Pharma Corporation Cash Flow Statement 2017年3月期 Mitsubishi Tanabe Pharma Corporation Cash Flow Statement 2016年3月期 Mitsubishi Tanabe Pharma Corporation Cash Flow Statement 2015年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2019 March 31, 2018 March 31, 2017 March 31, 2016 March 31, 2015
Operating Cash Flow(OFC)Help
(Percent)
41,460down
(72.6%)down
66,943up
(100.0%)
59,785down
(100.0%)
80,842up
(100.0%)up
68,167
(83.4%)
Investing Cash Flow(ICF)Help
(Percent)
-31,212down
(-54.7%)down
-19,178down
(-28.6%)down
-10,566up
(-17.7%)up
-42,213up
(-52.2%)up
-59,834
(-73.2%)
Financing Cash FlowHelp
(Percent)
-25,869up
(-45.3%)up
-32,501down
(-48.6%)down
-24,408down
(-40.8%)down
-22,236down
(-27.5%)down
-21,884
(-26.8%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0
-
0
-
0
-
0
-
0
-
Net Increase and Decrease in Cash and Cash Equivalentsn -15,621down
(-27.4%)down
15,264down
(22.8%)down
24,811up
(41.5%)up
16,393up
(20.3%)up
-13,551
(-16.6%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Mitsubishi Tanabe Pharma Corporation

Company where related level is highHelp

SymBio Pharmaceuticals Limited
StemRIM Inc.
Otsuka Holdings Co.,Ltd.
Cyfuse Biomedical K.K.
Solasia Pharma K.K.
CHUGAI PHARMACEUTICAL CO., LTD.
Nichi-Iko Pharmaceutical Co.,Ltd.
Nissui Pharmaceutical Co.,Ltd.
Modalis Therapeutics Corporation
Kringle Pharma,Inc.